… BRAF mutation occurs in papillary thyroid cancer (PTC) with a prevalence ranging from 29
to 83% (4–19). The T1799A BRAF mutation … aggressive when BRAF mutation was present. …

… Although we have previously investigated BRAF mutation in 13 matched primary tumor and
… the BRAF mutation was associated with prognostic factors such as age, sex, tumor size, …

… carcinomas, the most aggressive types of thyroid neoplasm. In addition, it is … thyroid tumors
and benign nodules for BRAF mutation, report a novel method of screening for the mutation, …

… the prevalence of the BRAF V600E mutation in pediatric papillary thyroid carcinoma (PTC) …
, the cumulative presence of BRAF V600E in pediatric thyroid cancer was 28.4% (Table 3). …

… good survival despite the aggressive clinical presentation. BRAF mutation has also been …
However, the reported rates of BRAF mutation vary significantly between studies. Lee et al. […

… the aggressive tumor behavior of BRAF+ PTC. The question arises whether BRAF mutation
plays a role as a prognostic marker, and how we should deal with BRAF+ tumors. This issue …

… In the current study, 95 specimens of thyroid tumors were subjected to BRAF mutation
analysis. The clinicopathological findings of all the specimen is presented in Table-1. The median …

… In PTC, TERT promoter mutation was more frequent in BRAF mutated tumors [31], which is
… promoter mutations, five (83.3%) had a coexisting BRAF mutation. TP53, a tumor suppressor …

… Many studies have shown an association of the BRAF V600E mutation with aggressive
clinicopathological characteristics of PTC, including LNM, extrathyroidal invasion, loss of …

… Recently, the relationship between the BRAF V600E mutation and a higher aggressiveness
of PTC has been attributed to a significantly higher expression of vascular endothelial …